中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Focus
Viral Diseases
NASH/PBC
Cancer
Exploratory Indications
Products&Pipeline
Pipeline
Products
Clinical Trials
Partnership
Investors
Financials & Filing
Presentation Materials
News
Careers
Investors
Financials & Filing
Presentation Materials
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2021
2021-11-03
Next Day Disclosure Returns - Share Buyback
2021-11-02
Next Day Disclosure Returns - Share Buyback
2021-11-01
Voluntary Announcement - Gannex Announces U.S. IND Approval of ASC43F, a First-in-class Dual-target fixed-Dose Combination for NASH
2021-11-01
Next Day Disclosure Returns - Share Buyback
2021-10-29
Next Day Disclosure Returns - Share Buyback
2021-10-28
Next Day Disclosure Returns - Share Buyback
2021-10-27
Next Day Disclosure Returns - Share Buyback
2021-10-26
Next Day Disclosure Returns - Share Buyback
2021-10-25
Next Day Disclosure Returns - Share Buyback
2021-10-22
«
3
4
5
6
»
